Biosimilar Equal to Natalizumab for Relapsing-Remitting MS ...Middle East

Medscape - News
A novel biosimilar matches natalizumab in terms of efficacy, safety, and immunogenicity in patients with relapsing remitting multiple sclerosis, results from a new phase 3 trial show. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Biosimilar Equal to Natalizumab for Relapsing-Remitting MS )

Apple Storegoogle play

Also on site :



Latest News